A distinct innate immune signature marks progression from mild to severe COVID-19

Mass cytometry and Olink data generated in the context of the characterization of the innate immune response to SARS-CoV-2 infection in a cohort of 70 covid-19 patients and 22 healthy individual collected in 4 hospital in Zürich (Switzerland) in spring 2020.

本数据集包含在2020年春季于瑞士苏黎世（Zürich）的四家医院对70名COVID-19患者及22名健康个体进行SARS-CoV-2感染先天免疫反应特征化研究时产生的流式细胞术和Olink数据。